DailyIQ
|
DailyIQ
|
Last updatedUpdating…

RCUS·Arcus Biosciences, Inc.

$0.00
+0.00 (+0.00%)
High
$0.00
Open
$0.00
Market Cap
2.82B
52W High
$32.00
Low
$0.00
P. Close
-
P/E
-
52W Low
$16.35
Fwd P/E
-7.08
DailyIQ Est.
-
Inst. Ownership
-
Short Interest
-
Days to Cover
7.6
Technical Score (1D)
89
BULLISH
News Sentiment
61
BULLISH
With a Technical Score of 89, Arcus Biosciences, Inc. (RCUS) sits in the upper tier of the momentum ranking on the 1D timeframe. The bullish bias and BUY signal follow from that rank, and trend strength reads as strong. Sentiment at 61 is aligned with the chart. Because the score is relative, it can stay high while the broader market falls, as long as RCUS holds up better than its peers. $21.61 is the near-term risk reference and $24.09 is the next upside marker if buyers keep pressing. DailyIQ's indicator breakdown shows how individual readings such as RSI (neutral range) and MACD (bearish) look right now. Those readings are context only and do not feed the Technical Score, which ranks RCUS's momentum against the rest of the universe.
RCUS|Analyst Targets
Bought (1Y)
0 shares
$0
Sold (1Y)
2,827 shares
$85K
Azoy AlexanderChief Accounting Officer
Option Exercise2,827 shares2026-08-21
Azoy AlexanderChief Accounting Officer
Sell2,827 shares2026-08-21
Azoy AlexanderChief Accounting Officer
Option Exercise2,827 shares2026-08-21
View full insider trading history →
10/ 100
Very bearish
Overall: Bearish
✕Revenue declining year over year
✕Negative net margin
✕Negative operating cash flow
Net Margin
-1069.7%
Revenue CAGR
48.3%
Current Ratio
4.36x
Debt / Equity
0.16x
Return on Equity
-55.9%
View full financials →

EPS

EstBeatMiss
$-1.35$-1.22$-1.09$-0.96$-0.83Q3'25Q3'26
QtrEstActual+/−
Q3'26$-0.89 - -
Q3'25$-1.29$-1.27+1.6%

Revenue

EstBeatMiss
$8M$13M$18M$23M$28MQ3'25Q3'26
QtrEstActual+/−
Q3'26$10M - -
Q3'25 - $26M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Sector Rotation

Is money rotating into or out of RCUS's sector?

Arcus Biosciences, Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, RCUS ranks 13th of 15 tracked industries, lagging.

Sector rank
#3 of 12
Sector state
Leading
Sector rotation score
82
Industry rank
#13 of 15

Options Market

What is the options market pricing for RCUS?

CallsPuts

For Arcus Biosciences, Inc.'s nearest expiry (2026-11-20, 33 days out), open interest is roughly balanced between puts and calls (put/call ratio of 1.11), with at-the-money implied volatility around 97.4%. The options market is pricing roughly a ±29.5% move by that expiry — a range of about $15.59–$28.65.

Put/call ratio (2026-11-20)
1.11
ATM implied volatility
97.4%
Total open interest
1,364
Expected move by 2026-11-20
±29.5% ($15.59–$28.65)

Corporate Stakes

Which companies own a stake in RCUS?

$968.8Mheld by GILD

Gilead Sciences, Inc. reports a stake in Arcus Biosciences, Inc. on SEC Form 13F: 31.4M shares worth $968.8M at the end of Q2 2026.

Holder
GILD
Shares held
31.4M
Value
$968.8M
HolderLast quarterShares% of RCUSValue at filingValue now
Gilead Sciences, Inc. GILDUnchanged31.4M-$968.8M-

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it.

News & sentiment

What is the news saying about RCUS?

RCUS fell 10.3% over the month to Oct 16. Daily news tone ranged from 50 to 58 and read 58 on Oct 16.

Daily close and news tone, Sep 16 to Oct 16
$22$24$26Sep 16Sep 17Sep 18Sep 21Sep 22Sep 23Sep 24Sep 25Sep 28Sep 29Sep 30Oct 1Oct 2Oct 5Oct 6Oct 7Oct 8Oct 9: tone 57Oct 12Oct 13Oct 14: tone 50Oct 15Oct 16: tone 58Sep 16News toneOct 16123
  1. Sep 17 +3.6%
  2. Sep 24 -5.0%same day: Arcus Biosciences Announces New Employment Inducement Grants
  3. Oct 13 -7.5%
Latest stories naming Arcus Biosciences

Technical analysis

How strong is RCUS's momentum right now?

On the daily chart RCUS ranks at the 89th percentile for momentum against 1,057 stocks and ETFs, a bullish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling RCUS?

41 of the 77 tracked managers added to RCUS in their latest 13F and 30 trimmed. Together their positions are worth $922.0M.

41adding30trimming6unchanged
Largest holders by stake, latest 13F
  1. 1State Street Corp
    $185.9M positionAdded 11.4% last quarter
  2. 2Vanguard Portfolio Management LLC
    $138.0M positionAdded 4.8% last quarter
  3. 3Vanguard Capital Management LLC
    $119.9M positionAdded 0.8% last quarter
  4. 4Woodline Partners LP
    $92.7M positionTrimmed 20.4% last quarter
  5. 5California State Teachers' Retirement System (CalSTRS)
    $97.4K positionAdded 2.9M shares last quarter
  6. 6Dimensional Fund Advisors LP
    $44.2M positionAdded 0.6% last quarter
  7. 7BNP Paribas Asset Management Holding S.A.
    $43.8M positionTrimmed 14.2% last quarter
  8. 8Charles Schwab Investment Management Inc
    $29.0M positionAdded 4.2% last quarter
  9. 9Baker Bros. Advisors LP
    $26.0M positionAdded 103.3% last quarter
  10. 10Candriam S.C.A.
    $20.4M positionTrimmed 16.3% last quarter
Full holdings history

Discover more

How has RCUS done against its peers?

Over the month to Oct 16, RCUS returned −9.0%. Of the 15 related stocks and ETFs, 13 did better, led by MRNA at +51.2%.

Change since Sep 15Through Oct 16
−20%−10%0%+10%+20%+30%+40%+50%+60%+70%Sep 15Oct 16MRNA +51.2%RCUS −9.0%ROIV −15.2%